Gunilla holds an MD, PhD and Associate Professor from Karolinska Insitute. Her wide-ranging experience covers all phases of drug development in small, medium and large companies. She is a co-founder of Gesynta Pharma and holds several board positions.
Holdings in the company: 60,710 shares and 27,710 warrants of series TO1
Independence: Gunilla is independent in relation to the company and is independent in relation to the Company’s largest shareholders.